Ion Channels Product Listing | Edition 1

Total Page:16

File Type:pdf, Size:1020Kb

Ion Channels Product Listing | Edition 1 Ion Channels Product Listing | Edition 1 Western Honey Bee Apis mellifera A source of Apamin Products by Gating Mechanism: • Ligand-gated Ion Channels • Voltage-gated Ion Channels • Other Ion Channels Tocris Product Listing Series Introduction Ion channels are pore-forming proteins present in the plasma membrane of most cells, as well as the intracellular membranes surrounding many organelles, allowing the passage of ions across the membrane. They are essential for maintaining resting membrane potential, generating action potentials and other electrical signaling, and regulating cell volume. Ion channels have a fundamental role in physiological processes such as T cell activation, muscle contraction, insulin release from pancreatic β cells and transport of nutrients and ions across epithelial cells. A huge variety of ion channels exist, exhibiting selective permeability to particular ions and having different gating mechanisms. Ion channels may be classified according to their ion selectivity or gating mechanism, i.e. how the flow of ions is controlled. We have followed the IUPHAR classification of ion channels for the purposes of this listing and grouped the products into three main sections according to gating mechanism: Ligand-gated Ion Channels, Voltage- gated Ion Channels, and Other Channels. Contents Ligand-gated Ion Channels 3 Potassium Channels 17 Ca2+-Activated Potassium Channels 17 5-HT3 4 Inward Rectifier Potassium (K ) Channels 18 Acetylcholine Nicotinic Receptors 4 ir Two-P Potassium Channels 19 Nicotinic (α7) Receptors 4 Voltage-gated Potassium (Kv) Channels 19 Nicotinic (α4β2) Receptors 6 Non-selective / Other Potassium Channels 19 Nicotinic Receptors (Non-selective/Other) 7 Sodium Channels 20 Acid-sensing Ion Channels 8 Voltage-gated Sodium Channels 20 Epithelial Sodium Channels 8 Transient Receptor Potential Channels 20 GABA and GABA Receptors 8 A A-ρ TRPA1 20 GABA Receptors 8 A TRPC 20 GABA Receptors 9 A-ρ TRPM 20 GABA Miscellaneous 9 TRPML 21 Glutamate (Ionotropic) Receptors 9 TRPP 21 AMPA Receptors 9 TRPV 21 Kainate Receptors 10 The Comprehensive in Vitro Proarrhythmia 23 NMDA Receptors 10 Assay Initiative (CiPA) Other Glutamate 12 Glycine Receptors 13 Other Channels 24 HCN Channels 13 Aquaporins 24 IP3 Receptors 13 Chloride Channels 24 Purinergic (P2X) Receptors 13 Calcium-activated Chloride Channels 24 CFTR 24 Voltage-gated Ion Channels 15 Other Chloride Channels 24 Calcium Channels 16 Ionophores 24 Ryanodine Receptors 16 Photoswitchable Ligands 25 STIM-Orai Channels 16 Other Channel Modulators 25 Voltage-gated Calcium Channels 16 Other Calcium Channels 17 Antibodies Targeting Ion Channels 26 References 27 Front cover image by Mikhail Laptev (https://www.dreamstime.com/royalty-free-stock-photography-honey-bee-apis-mellifera-dahlia-flower-image27164717) via dreamstime.com 2 | Ion channeLS Ligand-gated Ion channels Ligand-gated ion channels are a large group of transmembrane proteins that allow the passage of ions through the membrane in response to the binding of a specific chemical messenger; they are also known as ionotropic receptors. Ligand-gated ion channels are grouped according to the endogenous compound to which they selectively respond; these include 5-HT, ATP, GABA, glutamate, acetylcholine and glycine. In general, the binding site for the ligand is distinct from the pore, and binding results in either channel opening or closing. Figure 1 | A representation of the ligand-gated ion channel gene tree featuring genes of ion channels targeted by tocris products P2X ENaC P2RX1 P2RX6 SCNN1A P2RX2 SCNN1D P2RX4 SCNN1B P2RX5 P2RX7 SCNN1G P2RX3 ASIC2 ASIC1 ASIC ASIC3 ASIC4 ASIC5 GRIN2D GRIN2C GRIN3B NMDA GRIN2B GRIN1 GRIN3A GRIN2A GRIK5 GRIK4 GRIK3 GRIK2 Kainate GRIA4 GRIK1 GRIA2 GRIA3 AMPA GRIA1 CHRNA9 CHRNG nAChR CHRNA10 CHRNE CHRNB4 CHRND CHRNB2 CHRNB3 CHRNA7 CHRNB1 CHRNA CHRNA6 CHRNA3 CHRNA4 CHRNA1 CHRNA2 HTR3E HTR3C Gene Ion Channel 5-HT abbreviation HTR3D ASIC acid-sensing ion channel HTR3B CHRNA cholinergic receptor nicotinic alpha subunit HTR3A CHRNB cholinergic receptor nicotinic beta subunit CHRND cholinergic receptor nicotinic delta subunit GABRG2 GLRA3 CHRNE cholinergic receptor nicotinic epsilon subunit GLRA1 CHRNG cholinergic receptor nicotinic gamma subunit GABRG1 GABRA γ-aminobutyric acid type a receptor alpha subunit GLRA2 GABRB γ-aminobutyric acid type a receptor beta subunit GABRG3 GlyR GABRD γ-aminobutyric acid type a receptor delta subunit GABRE GLRA4 GABRE γ-aminobutyric acid type a receptor epsilon GABRR2 GLRB subunit GABRB1 GABRR1 GABRG γ-aminobutyric acid type a receptor gamma GABRQ subunit GABRR3 GABRB3 GABRP γ-aminobutyric acid type a receptor pi subunit GABRP GABRQ γ-aminobutyric acid type a receptor theta subunit GABRA6 GABRR γ-aminobutyric acid type a receptor rho subunit GABRB2 GABRD GRIA glutamate ionotropic receptor aMPa type subunit GRIK glutamate ionotropic receptor kainate type GABRA4 subunit GRIN glutamate ionotropic receptor nMDa type subunit GABRA2 GABAa GLRA glycine receptor alpha GABRA1 GLRB glycine receptor beta GABRA3 GABRA5 HTR3 5-hydroxytryptamine receptor 3 P2RX purinergic receptor P2X SCNN sodium channel epithelial (enac) adapted from www.guidetopharmacology.org www.tocris.com | 3 Tocris Product Listing Series Category Cat. no. Product name Description Unit size 5-HT3 Agonists 0440 m-chlorophenylbiguanide Potent and specific 5-hT3 agonist 100 mg 0558 2-Methyl-5-hydroxytryptamine 5-hT3 agonist/potent 5-hT6 ligand 10 mg 50 mg 0566 N-Methylquipazine 5-hT3 agonist 100 mg 0629 Quipazine 5-hT3 agonist 100 mg 0988 RS 56812 5-hT3 partial agonist 10 mg 50 mg 3547 Serotonin endogenous 5-hT receptor agonist 50 mg 1205 SR 57227 Potent, selective 5-hT3 agonist 10 mg 50 mg Antagonists 0666 3-aQc 5-hT3 antagonist 10 mg 50 mg 2759 B-hT 920 5-hT3 antagonist; also α2 agonist and D2 receptor agonist 10 mg 50 mg 0475 Dihydroergotamine non-selective 5-hT antagonist; also partial α agonist 100 mg 5629 Dolasetron Potent and selective 5-hT3 antagonist 10 mg 50 mg 2903 Granisetron 5-hT3 antagonist 10 mg 50 mg 0640 MDL 72222 5-hT3 antagonist 50 mg 2018 Mirtazapine 5-hT3, 5-hT2, h1 and α2-antagonist; antidepressant 10 mg 50 mg 2844 Mosapride citrate 5-hT3 antagonist and 5-hT4 agonist 10 mg 50 mg 2891 ondansetron Selective 5-hT3 antagonist 10 mg 50 mg 2037 SDZ 205-557 5-hT3 and 5-hT4 receptor antagonist 10 mg 50 mg 0641 Tropanyl-3,5-dimethylbenzoate 5-hT3 antagonist 100 mg 2459 Tropisetron Potent 5-hT3 receptor antagonist; also partial agonist of α7 nachR 10 mg 50 mg 4532 VUF 10166 high affinity 5-hT3 receptor antagonist 10 mg 50 mg 0380 Y-25130 Potent, selective 5-hT3 antagonist 10 mg 50 mg 1795 Zacopride highly potent 5-hT3 receptor antagonist; also 5-hT4 agonist 10 mg 50 mg Acetylcholine Nicotinic Receptors nicotinic (α7) Receptors Agonists 4234 4BP-TQS allosteric agonist at α7 nachR 10 mg 4341 a 582941 Partial agonist at α7 nachR 10 mg 50 mg 4477 a 844606 Selective α7 nachR partial agonist 10 mg 50 mg 2809 acetylcholine endogenous neurotransmitter 50 mg 3964 aR-R 17779 α7-selective agonist 10 mg 2241 DMaB-anabaseine Partial agonist at α7 nachR; also α4β2 antagonist 10 mg 50 mg 4557 GTS 21 Partial agonist at α7 nachR 10 mg 50 mg 3092 Pha 543613 Potent and selective α7 nachR agonist 10 mg 3134 Pha 568487 α7-selective agonist 10 mg 50 mg 2303 PnU 282987 Selective α7 nachR agonist 10 mg 50 mg 4 | Ion channeLS Ligand-gated Ion channels – continued Ion Channels in Immunology Research T and B cells and microglia express a wide variety of ion channels, which are implicated in immune processes. Below is a selection of compounds from Tocris that may be used to explore the role of ion channels in the immune system. N N OMe N N N N N Cl O NaO3S Cl O NaO3S NaO3S HN A 438079 (2972) OMe HN SO3Na Competitive P2X7 receptor antagonist P2X7 receptors expressed on T cells and O microglia are associated with cell migration, SKF 96365 (1147) Inhibits STIM1-mediated Ca2+ HN proliferation, and cytokine release as well as O Th17 differentiation. influx; also TRPC channel inhibitor HN Calcium is a second messenger in O lymphocytes, regulating proliferation, gene expression, motility and other functions. STIM1 is the putative Ca2+ sensor on the HN SO3Na endoplasmic reticulum (ER). NaO3S HN O NaO3S O S N NaO3S N Cl O NF 449 (1391) N N Potent and selective P2X H H 1 receptor antagonist TRAM 34 (2946) OH P2X1 receptors are expressed on Potent and highly selective KCa 3.1 5J 4 (5490) T cells and are associated activation. channel blocker CRAC channel blocker; blocks Potassium channels regulate the membrane store-operated calcium entry potential of lymphocytes and KCa3.1 CRAC channels are expressed in channels are associated with membrane lymphocytes and are activated in response hyperpolarization in response to elevated to depleted intracellular Ca2+ stores. 2+ intracellular Ca levels. 2+ Ca release from ER is triggered by IP3 in response to antigen receptor activation. Category Cat. no. Product name Description Unit size 1271 RJR 2429 nicotinic receptor agonist 10 mg Immunology feature products 50 mg 3518 S 24795 Partial agonist at α7 nachR 10 mg 50 mg 4441 Sen 12333 α7 nachR agonist; histamine h3 antagonist 10 mg 50 mg 5559 SSR 180711 Partial agonist at α7 nachR 10 mg 50 mg 2518 Tc 1698 α7-selective agonist 10 mg 50 mg Antagonists 2133 α-Bungarotoxin α7 subtype-selective nachR antagonist 1 mg 3119 α-conotoxin ImI α7 and α9 selective nachR antagonist 500 μg 3405 coG 133 nicotinic α7 antagonist; apoe peptide fragment 1 mg 1029 Methyllycaconitine α7 neuronal nicotinic receptor antagonist 5 mg 25 mg 1356 MG
Recommended publications
  • Synthesis of Conformationally Constrained Glutamate Analogues and Their Preliminary Evaluation As Glutamate Transport Inhibitors
    University of Montana ScholarWorks at University of Montana Graduate Student Theses, Dissertations, & Professional Papers Graduate School 2002 Synthesis of conformationally constrained glutamate analogues and their preliminary evaluation as glutamate transport inhibitors Travis Taylor Denton The University of Montana Follow this and additional works at: https://scholarworks.umt.edu/etd Let us know how access to this document benefits ou.y Recommended Citation Denton, Travis Taylor, "Synthesis of conformationally constrained glutamate analogues and their preliminary evaluation as glutamate transport inhibitors" (2002). Graduate Student Theses, Dissertations, & Professional Papers. 9450. https://scholarworks.umt.edu/etd/9450 This Dissertation is brought to you for free and open access by the Graduate School at ScholarWorks at University of Montana. It has been accepted for inclusion in Graduate Student Theses, Dissertations, & Professional Papers by an authorized administrator of ScholarWorks at University of Montana. For more information, please contact [email protected]. INFORMATION TO USERS This manuscript has been reproduced from the microfilm master. UMI films the text directly from the original or copy submitted. Thus, some thesis and dissertation copies are in typewriter face, while others may be from any type of computer printer. The quality of this reproduction is dependent upon the quality of the copy submitted. Broken or indistinct print, colored or poor quality illustrations and photographs, print bleedthrough, substandard margins, and improper alignment can adversely affect reproduction. In the unlikely event that the author did not send UMI a complete manuscript and there are missing pages, these will be noted. Also, if unauthorized copyright material had to be removed, a note will indicate the deletion.
    [Show full text]
  • Chemicals in the Fourth Report and Updated Tables Pdf Icon[PDF
    Chemicals in the Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 CDC’s Fourth National Report on Human Exposure to Environmental Chemicals: Updated Tables, March 2021 provides exposure data on the following chemicals or classes of chemicals. The Updated Tables contain cumulative data from national samples collected beginning in 1999–2000 and as recently as 2015-2016. Not all chemicals were measured in each national sample. The data tables are available at https://www.cdc.gov/exposurereport. An asterisk (*) indicates the chemical has been added since publication of the Fourth National Report on Human Exposure to Environmental Chemicals in 2009. Adducts of Hemoglobin Acrylamide Formaldehyde* Glycidamide Tobacco Alkaloids and Metabolites Anabasine* Anatabine* Cotinine Cotinine-n-oxide* Hydroxycotinine* Trans-3’-hydroxycotinine* 1-(3-Pyridyl)-1-butanol-4-carboxylic acid* Nicotine* Nicotine-N’-oxide* Nornicotine* Tobacco-Specific Nitrosamines (TSNAs) N’-Nitrosoanabasine (NAB)* N’-Nitrosoanatabine (NAT)* N’-Nitrosonornicotine (NNN)* Total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol) (NNAL)* Volatile N-nitrosamines (VNAs) N-Nitrosodiethylamine (NDEA)* N-Nitrosoethylmethylamine (NMEA)* N-Nitrosomorpholine (NMOR)* N-Nitrosopiperidine (NPIP)* N-Nitrosopyrrolidine (NPYR)* Disinfection By-Products Bromodichloromethane Dibromochloromethane Tribromomethane (Bromoform) Trichloromethane (Chloroform) Personal Care and Consumer Product Chemicals and Metabolites Benzophenone-3 Bisphenol A Bisphenol F* Bisphenol
    [Show full text]
  • Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
    Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence Christie D. Fowler, Jill R. Turner, and M. Imad Damaj Contents 1 Introduction 2 Basic Neurocircuitry of Nicotine Addiction 3 Role of Nicotinic Receptors in Nicotine Dependence and Brain Function 4 Modulatory Factors That Influence nAChR Expression and Signaling 5 Genomics and Genetics of Nicotine Dependence 5.1 Overview 5.2 Human and Animal Genetic Studies 5.3 Transcriptionally Adaptive Changes 6 Other Constituents in Nicotine and Tobacco Products Mediating Dependence 7 Therapeutic Approaches for Tobacco and Nicotine Dependence 7.1 Nicotine Replacement Therapies 7.2 Varenicline and Bupropion 7.3 Novel Approaches 8 Conclusion References Abstract Tobacco dependence is a leading cause of preventable disease and death world- wide. Nicotine, the main psychoactive component in tobacco cigarettes, has also C. D. Fowler Department of Neurobiology and Behavior, University of California Irvine, Irvine, CA, USA J. R. Turner Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, Lexington, KY, USA M. Imad Damaj (*) Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA Translational Research Initiative for Pain and Neuropathy at VCU, Richmond, VA, USA e-mail: [email protected] # Springer Nature Switzerland AG 2019 Handbook of Experimental Pharmacology, https://doi.org/10.1007/164_2019_252 C. D. Fowler et al. been garnering increased popularity in its vaporized form, as derived from e-cigarette devices. Thus, an understanding of the molecular mechanisms under- lying nicotine pharmacology and dependence is required to ascertain novel approaches to treat drug dependence. In this chapter, we review the field’s current understanding of nicotine’s actions in the brain, the neurocircuitry underlying drug dependence, factors that modulate the function of nicotinic acetylcholine receptors, and the role of specific genes in mitigating the vulnerability to develop nicotine dependence.
    [Show full text]
  • Combined Pharmacological Administration of AQP1 Ion Channel
    www.nature.com/scientificreports OPEN Combined pharmacological administration of AQP1 ion channel blocker AqB011 and water channel Received: 15 November 2018 Accepted: 13 August 2019 blocker Bacopaside II amplifes Published: xx xx xxxx inhibition of colon cancer cell migration Michael L. De Ieso 1, Jinxin V. Pei 1, Saeed Nourmohammadi1, Eric Smith 1,2, Pak Hin Chow1, Mohamad Kourghi1, Jennifer E. Hardingham 1,2 & Andrea J. Yool 1 Aquaporin-1 (AQP1) has been proposed as a dual water and cation channel that when upregulated in cancers enhances cell migration rates; however, the mechanism remains unknown. Previous work identifed AqB011 as an inhibitor of the gated human AQP1 cation conductance, and bacopaside II as a blocker of AQP1 water pores. In two colorectal adenocarcinoma cell lines, high levels of AQP1 transcript were confrmed in HT29, and low levels in SW480 cells, by quantitative PCR (polymerase chain reaction). Comparable diferences in membrane AQP1 protein levels were demonstrated by immunofuorescence imaging. Migration rates were quantifed using circular wound closure assays and live-cell tracking. AqB011 and bacopaside II, applied in combination, produced greater inhibitory efects on cell migration than did either agent alone. The high efcacy of AqB011 alone and in combination with bacopaside II in slowing HT29 cell motility correlated with abundant membrane localization of AQP1 protein. In SW480, neither agent alone was efective in blocking cell motility; however, combined application did cause inhibition of motility, consistent with low levels of membrane AQP1 expression. Bacopaside alone or combined with AqB011 also signifcantly impaired lamellipodial formation in both cell lines. Knockdown of AQP1 with siRNA (confrmed by quantitative PCR) reduced the efectiveness of the combined inhibitors, confrming AQP1 as a target of action.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Targeting Ion Channels in Cancer: a Novel Frontier in Antineoplastic Therapy A
    66 Current Medicinal Chemistry, 2009, 16, 66-93 Targeting Ion Channels in Cancer: A Novel Frontier in Antineoplastic Therapy A. Arcangeli*,1, O. Crociani1, E. Lastraioli1, A. Masi1, S. Pillozzi1 and A. Becchetti2 1Department of Experimental Pathology and Oncology, University of Firenze, Italy; 2Department of Biotechnology and Biosciences, University of Milano-Bicocca, Italy Abstract: Targeted therapy is considerably changing the treatment and prognosis of cancer. Progressive understanding of the molecular mechanisms that regulate the establishment and progression of different tumors is leading to ever more spe- cific and efficacious pharmacological approaches. In this picture, ion channels represent an unexpected, but very promising, player. The expression and activity of different channel types mark and regulate specific stages of cancer progression. Their contribution to the neoplastic phenotype ranges from control of cell proliferation and apoptosis, to regulation of invasiveness and metastatic spread. As is being in- creasingly recognized, some of these roles can be attributed to signaling mechanisms independent of ion flow. Evidence is particularly extensive for K+ channels. Their expression is altered in many primary human cancers, especially in early stages, and they frequently exert pleiotropic effects on the neoplastic cell physiology. For instance, by regulating membrane potential they can control Ca2+ fluxes and thus the cell cycle machinery. Their effects on mitosis can also de- pend on regulation of cell volume, usually in cooperation with chloride channels. However, ion channels are also impli- cated in late neoplastic stages, by stimulating angiogenesis, mediating the cell-matrix interaction and regulating cell motil- ity. Not surprisingly, the mechanisms of these effects are manifold.
    [Show full text]
  • Transcriptomic Analysis of Native Versus Cultured Human and Mouse Dorsal Root Ganglia Focused on Pharmacological Targets Short
    bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-ND 4.0 International license. Transcriptomic analysis of native versus cultured human and mouse dorsal root ganglia focused on pharmacological targets Short title: Comparative transcriptomics of acutely dissected versus cultured DRGs Andi Wangzhou1, Lisa A. McIlvried2, Candler Paige1, Paulino Barragan-Iglesias1, Carolyn A. Guzman1, Gregory Dussor1, Pradipta R. Ray1,#, Robert W. Gereau IV2, # and Theodore J. Price1, # 1The University of Texas at Dallas, School of Behavioral and Brain Sciences and Center for Advanced Pain Studies, 800 W Campbell Rd. Richardson, TX, 75080, USA 2Washington University Pain Center and Department of Anesthesiology, Washington University School of Medicine # corresponding authors [email protected], [email protected] and [email protected] Funding: NIH grants T32DA007261 (LM); NS065926 and NS102161 (TJP); NS106953 and NS042595 (RWG). The authors declare no conflicts of interest Author Contributions Conceived of the Project: PRR, RWG IV and TJP Performed Experiments: AW, LAM, CP, PB-I Supervised Experiments: GD, RWG IV, TJP Analyzed Data: AW, LAM, CP, CAG, PRR Supervised Bioinformatics Analysis: PRR Drew Figures: AW, PRR Wrote and Edited Manuscript: AW, LAM, CP, GD, PRR, RWG IV, TJP All authors approved the final version of the manuscript. 1 bioRxiv preprint doi: https://doi.org/10.1101/766865; this version posted September 12, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Poster Abstracts
    POSTER ABSTRACTS Society of Toxicology (MASOT) www.masot.org Fall 2015 Scientific Meeting October 13th, 2015 Abstract 01 Tracking Inflammatory Macrophage Accumulation in the Lung during Ozone- induced Lung Injury in Mice M Francis, M Mandal, C. Sun, H Choi, JD Laskin, DL Laskin Rutgers University, Piscataway, NJ Ozone induced lung injury is associated with an accumulation of pro- and antiinflammatory macrophages (MP) in the lung which have been implicated in tissue injury and repair. In these studies, we used in vivo tracking techniques to investigate the origin of cell. Initially we generated bone marrow (BM) chimeric mice by adoptive transfer of BM cells from GFP+ mice into irradiated C57BL/6 mice. After 4 weeks, mice were exposed to air or ozone (0.8 ppm, 3 h). Macrophages were isolated from lungs 24- 72 h later, stained with fluorescent labeled antibodies, and analyzed by flow cytometry. Approximately 98% of BM cells were found to be GFP+ while only 5% were GFP+ in control lungs. Ozone exposure resulted in a marked increase in infiltrating mature GFP+CD11b+F4/80+ MP into the lung. Two populations, Ly6CHi proinflammatory and Ly6CLo antiinflammatory were identified. Proinflammatory GFP+Ly6CHi MP increased rapidly after ozone and remained elevated, increases in antiinflammatory GFP+Ly6CLo were transient. To assess potential mechanisms mediating the accumulation of these MP subpopulations in the lung, we used mice lacking Ccr2, a chemokine receptor involved in proinflammatory MP trafficking. Loss of Ccr2 resulted in decreased numbers of infiltrating CD11b+ MP in the lung. This was due to a selective reduction in proinflammatory Ly6CHi MP.
    [Show full text]
  • Expression Profiling of Ion Channel Genes Predicts Clinical Outcome in Breast Cancer
    UCSF UC San Francisco Previously Published Works Title Expression profiling of ion channel genes predicts clinical outcome in breast cancer Permalink https://escholarship.org/uc/item/1zq9j4nw Journal Molecular Cancer, 12(1) ISSN 1476-4598 Authors Ko, Jae-Hong Ko, Eun A Gu, Wanjun et al. Publication Date 2013-09-22 DOI http://dx.doi.org/10.1186/1476-4598-12-106 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Ko et al. Molecular Cancer 2013, 12:106 http://www.molecular-cancer.com/content/12/1/106 RESEARCH Open Access Expression profiling of ion channel genes predicts clinical outcome in breast cancer Jae-Hong Ko1, Eun A Ko2, Wanjun Gu3, Inja Lim1, Hyoweon Bang1* and Tong Zhou4,5* Abstract Background: Ion channels play a critical role in a wide variety of biological processes, including the development of human cancer. However, the overall impact of ion channels on tumorigenicity in breast cancer remains controversial. Methods: We conduct microarray meta-analysis on 280 ion channel genes. We identify candidate ion channels that are implicated in breast cancer based on gene expression profiling. We test the relationship between the expression of ion channel genes and p53 mutation status, ER status, and histological tumor grade in the discovery cohort. A molecular signature consisting of ion channel genes (IC30) is identified by Spearman’s rank correlation test conducted between tumor grade and gene expression. A risk scoring system is developed based on IC30. We test the prognostic power of IC30 in the discovery and seven validation cohorts by both Cox proportional hazard regression and log-rank test.
    [Show full text]
  • Effects of Aquaporin 4 and Inward Rectifier
    9-Experimental Surgery Effects of aquaporin 4 and inward rectifier potassium channel 4.1 on medullospinal edema after methylprednisolone treatment to suppress acute spinal cord injury in rats1 Ye LiI, Haifeng HuII, Jingchen LiuIII, Qingsan ZhuIV, Rui GuV IAssociate Professor, Department of Orthopaedics, China-Japan Union Hospital, Jilin University, Changchun, China. Conception, design, intellectual and scientific content of the study; acquisition of data; manuscript writing; critical revision. IIAttending Doctor, Department of Orthopaedics, China-Japan Union Hospital, Jilin University, Changchun, China. Acquisition of data, manuscript writing. IIIProfessor, Department of Orthopaedics, China-Japan Union Hospital, Jilin University, Changchun, China. Scientific content of the study, acquisition of data, manuscript writing. IVProfessor, Department of Orthopaedics, China-Japan Union Hospital, Jilin University, Changchun, China. Acquisition of data. VProfessor, Department of Orthopaedics, China-Japan Union Hospital, Jilin University, Changchun, China. Intellectual, scientific, conception and design of the study; critical revision. Abstract Purpose: To investigate the effects of aquaporin 4 (AQP4) and inward rectifier potassium channel 4.1 (Kir4.1) on medullospinal edema after treatment with methylprednisolone (MP) to suppress acute spinal cord injury (ASCI) in rats. Methods: Sprague Dawley rats were randomly divided into control, sham, ASCI, and MP- treated ASCI groups. After the induction of ASCI, we injected 30 mg/kg MP via the tail vein at various time points. The Tarlov scoring method was applied to evaluate neurological symptoms, and the wet–dry weights method was applied to measure the water content of the spinal cord. Results: The motor function score of the ASCI group was significantly lower than that of the sham group, and the spinal water content was significantly increased.
    [Show full text]
  • The Chondrocyte Channelome: a Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities
    Old Dominion University ODU Digital Commons Biological Sciences Theses & Dissertations Biological Sciences Summer 2017 The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities Anthony J. Asmar Old Dominion University, [email protected] Follow this and additional works at: https://digitalcommons.odu.edu/biology_etds Part of the Biology Commons, Molecular Biology Commons, and the Physiology Commons Recommended Citation Asmar, Anthony J.. "The Chondrocyte Channelome: A Novel Ion Channel Candidate in the Pathogenesis of Pectus Deformities" (2017). Doctor of Philosophy (PhD), Dissertation, Biological Sciences, Old Dominion University, DOI: 10.25777/pyha-7838 https://digitalcommons.odu.edu/biology_etds/19 This Dissertation is brought to you for free and open access by the Biological Sciences at ODU Digital Commons. It has been accepted for inclusion in Biological Sciences Theses & Dissertations by an authorized administrator of ODU Digital Commons. For more information, please contact [email protected]. THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES by Anthony J. Asmar B.S. Biology May 2010, Virginia Polytechnic Institute M.S. Biology May 2013, Old Dominion University A Dissertation Submitted to the Faculty of Old Dominion University in Partial Fulfillment of the Requirements for the Degree of DOCTOR OF PHILOSOPHY BIOMEDICAL SCIENCES OLD DOMINION UNIVERSITY August 2017 Approved by: Christopher Osgood (Co-Director) Michael Stacey (Co-Director) Lesley Greene (Member) Andrei Pakhomov (Member) Jing He (Member) ABSTRACT THE CHONDROCYTE CHANNELOME: A NOVEL ION CHANNEL CANDIDATE IN THE PATHOGENESIS OF PECTUS DEFORMITIES Anthony J. Asmar Old Dominion University, 2017 Co-Directors: Dr. Christopher Osgood Dr. Michael Stacey Costal cartilage is a type of rod-like hyaline cartilage connecting the ribs to the sternum.
    [Show full text]
  • Goblet Cell LRRC26 Regulates BK Channel Activation and Protects Against Colitis in Mice
    Goblet cell LRRC26 regulates BK channel activation and protects against colitis in mice Vivian Gonzalez-Pereza,1, Pedro L. Martinez-Espinosaa, Monica Sala-Rabanala, Nikhil Bharadwaja, Xiao-Ming Xiaa, Albert C. Chena,b, David Alvaradoc, Jenny K. Gustafssonc,d,e, Hongzhen Hua, Matthew A. Ciorbab, and Christopher J. Linglea aDepartment of Anesthesiology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110; bMcKelvey School of Engineering, Washington University in St. Louis, St. Louis, MO 63130; cDepartment of Internal Medicine, Division of Gastroenterology, Washington University School of Medicine in St. Louis, St. Louis, MO 63110; dDepartment of Medical Chemistry and Cell Biology, University of Gothenburg, 405 30 Gothenburg, Sweden; and eDepartment of Physiology, University of Gothenburg, 405 30 Gothenburg, Sweden Edited by Richard W. Aldrich, The University of Texas at Austin, Austin, TX, and approved December 21, 2020 (received for review September 16, 2020) Goblet cells (GCs) are specialized cells of the intestinal epithelium Despite this progress, ionic transport in GCs and its implications contributing critically to mucosal homeostasis. One of the func- in GC physiology is a topic that remains poorly understood. tions of GCs is to produce and secrete MUC2, the mucin that forms Here, we address the role of the Ca2+- and voltage-activated K+ the scaffold of the intestinal mucus layer coating the epithelium channel (BK channel) in GCs. and separates the luminal pathogens and commensal microbiota GCs play two primary roles: One related to the maintenance from the host tissues. Although a variety of ion channels and of the mucosal barrier (reviewed in refs.
    [Show full text]